Medical Oncologist
CION Cancer Clinics
'Likely pathogenic': how sure is this result? | CION Cancer Clinics
Likely pathogenic means the evidence points the same way as pathogenic, without quite reaching a laboratory's highest confidence bar. In the clinic it is treated exactly the same way. This page explains why the word 'likely' appears, what happens next, and why waiting for a firmer result is not what your care team will do. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does 'likely pathogenic' mean, and how sure is it?
- Four reasons a finding stops just short of pathogenic
- What follows a likely pathogenic result
- Words worth knowing for this classification
- Likely pathogenic and pathogenic, compared
- What this page cannot tell you
- Four things people assume about 'likely pathogenic'
- Common questions about a likely pathogenic result
The short answer
What does 'likely pathogenic' mean, and how sure is it?
Likely pathogenic means the evidence points the same way as a pathogenic result, but has not yet reached the highest bar of certainty a laboratory sets before it will drop the word "likely". In the clinic, it is treated the same as pathogenic. Screening, treatment discussions and family testing all go ahead exactly as they would for the firmer of the two words.
Certain enough to act on, not certain enough to call outright
Laboratories set a very high bar before writing "pathogenic" alone, because so much follows from that single word. "Likely pathogenic" exists for the many real findings that clear a high bar of confidence without quite reaching the very highest one, often simply because the change is rare and has not yet been seen and studied as many times as an older, more common one.
Why this is not a weaker result to worry about
Families sometimes read "likely" the way they would in ordinary conversation, as a guess. Here it is not a guess. It describes how much published evidence exists, not how confident your medical team is. Your oncologist and counsellor will act on it as they would act on a pathogenic finding. Some laboratories even describe both tiers together as "positive" in a covering letter, precisely so a family does not read more caution into the second word than the evidence actually carries.
Likely pathogenic changes your care in the same way pathogenic does. The word describes the evidence, not the plan.Why the word 'likely' appears
Four reasons a finding stops just short of pathogenic
The change is rare
A spelling difference nobody has reported before simply has less published evidence behind it than one seen in many families already.
Computer prediction only
Software can estimate how damaging a change looks, but a prediction alone rarely clears the bar for the top classification on its own.
The family is small
Tracking a change across relatives who did and did not develop cancer strengthens a classification. A small family simply cannot supply as much of that evidence.
No laboratory study yet
A direct laboratory test of what the change does to the protein is the strongest evidence of all, and it does not exist for every variant yet. Such studies take time and funding to run, so many genuine faults simply have not been through one.
Not sure whether this applies to you?
Ask an oncologistWhat happens from here
What follows a likely pathogenic result
-
Your care team acts on it now
Screening and treatment planning start straight away, without waiting to see whether the classification is later firmed up.
-
Relatives can be offered testing
The same targeted, single-gene test can be offered to close relatives, exactly as it would be for a pathogenic result.
-
The evidence keeps being added to
As more families and laboratories report the same change, the classification is revisited using the growing body of evidence.
-
It may move, or it may stay exactly where it is
Most likely pathogenic findings simply stay that way for good. A move to pathogenic, when it happens, changes nothing about your existing plan.
On your report
Words worth knowing for this classification
- Likely pathogenic
- Strong evidence that a change breaks a gene's normal function, just short of the laboratory's top confidence threshold.
- Confidence threshold
- The fixed bar of combined evidence a laboratory requires before writing "pathogenic" alone, without "likely" attached.
- In silico prediction
- A computer estimate of how damaging a change looks. Useful as one piece of evidence, never enough evidence on its own.
- Segregation
- Whether a change is found consistently in relatives who have cancer and absent in those who do not, across the family tree.
- ClinVar
- The shared public database where laboratories record classifications, so evidence from more than one centre can add up.
- Functional study
- A direct laboratory test of what a change does to the gene's product, rather than a prediction of what it might do.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Likely pathogenic and pathogenic, compared
Likely pathogenic
Pathogenic
Strong evidence, just short of the top threshold
Evidence has cleared the highest confidence bar
Often a rarer change with less published data
Often already reported in many families
Screening and treatment planning proceed as normal
Screening and treatment planning proceed as normal
Family testing is offered for the exact change
Family testing is offered for the exact change
Being straight with you
What this page cannot tell you
It cannot tell you whether your particular change will ever be upgraded to pathogenic. Most likely pathogenic findings never need to be, because they already carry enough weight to act on. Waiting for a firmer word before making decisions is rarely the right approach.
It cannot replace your counsellor's reading of your file
The same wording can sit differently depending on the gene involved and your own family history. Bring your report to the counsellor or oncologist who is following your case rather than treating this page as the final word on your result. Two families can hold reports that use the identical phrase and still be given quite different advice, because the gene, the pattern of illness in the family, and the person's own health history all shape what a counsellor recommends.
Who this page is not written for
If your report says uncertain significance, likely benign or benign, this page does not describe your result, and a different approach applies. Only pathogenic and likely pathogenic behave the way this page describes.
If you are unsure which classification your report actually uses, call the helpline and read the exact wording out to someone who can check.Commonly believed
Four things people assume about 'likely pathogenic'
"Likely means there is an even chance either way."
It does not describe a fifty-fifty chance. It describes strong evidence that has not yet reached the very top threshold. Clinically it is treated the same as pathogenic.
"It will definitely be upgraded eventually."
Some are, most simply stay as they are indefinitely, because the existing evidence is already considered enough to act on for good.
"Since it is not fully certain, I can wait to act."
Screening and family testing normally begin straight away. Waiting for a stronger word before acting is not what doctors recommend for this classification.
"A second test could give a more definite answer."
Repeating the same test gives the same result. What changes a classification is new evidence gathered over time across many families, not retesting one person again.
Questions we are asked
Common questions about a likely pathogenic result
Is likely pathogenic treated differently from pathogenic?
No. Your care team acts on both in the same way. The word "likely" describes how the evidence is worded, not how seriously your medical team takes the finding.
Should I wait for a firmer result before telling my family?
No. Relatives can be offered testing for the exact change now. Waiting only delays a conversation that does not need to wait.
Why didn't the laboratory just say pathogenic?
Because the framework used worldwide sets a very high, specific bar before dropping the word "likely", and this finding has not quite crossed it yet, usually because it is rare.
Can this classification be downgraded instead of upgraded?
It is uncommon but not impossible if later evidence points the other way. This is one reason staying in contact with the testing laboratory or clinic matters over the years.
Does the gene involved change what this result means?
Yes, considerably. Different genes carry different risks and call for different screening plans. The gene name matters as much as the classification word.
Can I get a second opinion on the classification itself?
Yes. A counsellor can check the finding against public variant databases where other laboratories record their own classifications of the same change.
Does this affect my existing treatment plan immediately?
If you already have cancer, your oncologist will tell you whether this finding changes anything about your current treatment, which depends on the specific gene and your situation.
Who can tell me exactly what my result means?
A genetic counsellor or clinical geneticist working from your full report. What your specific variant means for you is a question for the counsellor who ordered the test.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- MedlinePlus Genetics — What do the results of genetic tests mean?
- NHS — Predictive genetic tests for cancer risk genes
- Cancer Research UK — Inherited cancer genes and increased cancer risk
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
'Pathogenic' on your report: what it meansThe neighbouring, firmer tierThe five variant classifications explainedHow this tier fits among all fiveWhy two labs can classify the same variant differentlyWhy the exact wording can vary between reportsVariant reclassification: when a result changes years laterWhat it means if this classification is ever revised
Talk to us
Told your result is likely pathogenic and not sure what changes?
Tell us the gene named on your report. We will explain, in plain language, what usually happens next and help you get the right appointment. One helpline serves every CION centre.